SYDNEY, Dec. 10, 2024 /PRNewswire/ -- Syntara Limited (ASX:SNT), a clinical-stage drug development company, is pleased to announce positive interim data from its ongoing Phase 2 clinical trial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback